Article (Scientific journals)
Intercellular Epigenomic Signalling via Extracellular Vesicles During B Cell Maturation.
Yim, Kevin Ho Wai; Al Hrout, Ala'a; CHAHWAN, Richard
2025In Journal of Extracellular Vesicles, 14 (1), p. 70040
Peer Reviewed verified by ORBi
 

Files


Full Text
J of Extracellular Vesicle - 2025 - Yim - Intercellular Epigenomic Signalling via Extracellular Vesicles During B Cell.pdf
Author postprint (4.18 MB)
Download

All documents in ORBilu are protected by a user license.

Send to



Details



Keywords :
antibody maturation; extracellular vesicles; intercellular epigenomic signalling; non‐coding RNA; single particle analysis; MicroRNAs; Humans; Signal Transduction; MicroRNAs/metabolism; MicroRNAs/genetics; Animals; Mice; Cell Differentiation; Extracellular Vesicles/metabolism; B-Lymphocytes/metabolism; B-Lymphocytes/cytology; B-Lymphocytes/immunology; Epigenomics/methods; B-Lymphocytes; Epigenomics; RNA, Long Noncoding; Histology; Cell Biology
Abstract :
[en] B cell maturation is crucial for effective adaptive immunity. It requires a complex signalling network to mediate antibody diversification through mutagenesis. B cells also rely on queues from other cells within the germinal centre. Recently, a novel class of intercellular signals mediated by extracellular vesicles (EVs) has emerged. Studies have shown that B cell EV-mediated signalling is involved in immune response regulation and tumorigenesis. However, the mechanistic role of B cell EVs is not yet established. We herein study the biological properties and physiological function of B cell EVs during B cell maturation. We use emerging technologies to profile B cell EV surface marker signatures at the single particle level, molecular cargo and physiological roles in B cell maturation. EV ncRNA cargo, characterised by RNA-seq, identified an EV-mediated novel non-coding RNA (ncRNA) regulatory network for B cell maturation. We show that a previously uncharacterised micro-RNA (miR-5099) in combination with a set of long ncRNA are carried within B cell EVs and could contribute to antibody diversification. The physiological role of EVs in B cell maturation is investigated using EV blockade assays and complementation studies using diverse EV sources further confirmed the physiological role and mode of action of EVs in B cell maturation.
Disciplines :
Immunology & infectious disease
Biochemistry, biophysics & molecular biology
Genetics & genetic processes
Immunology & infectious disease
Author, co-author :
Yim, Kevin Ho Wai;  Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland ; EVIIVE AG, Zurich, Switzerland
Al Hrout, Ala'a ;  Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland
CHAHWAN, Richard  ;  University of Luxembourg ; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland ; EVIIVE AG, Zurich, Switzerland
External co-authors :
yes
Language :
English
Title :
Intercellular Epigenomic Signalling via Extracellular Vesicles During B Cell Maturation.
Publication date :
January 2025
Journal title :
Journal of Extracellular Vesicles
eISSN :
2001-3078
Publisher :
John Wiley and Sons Inc, United States
Volume :
14
Issue :
1
Pages :
e70040
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Vontobel-Stiftung
Novartis Foundation
Funding text :
We thank the Exeter Sequencing facility particularly Paul O'Neil and Karen Moore for help and advice. Christian Hacker and UZH microscopy facility for TEM support and advice. Bogdan Mateescu for discussions. Profs Matthew Scharff and Christian M\u00FCnz for critical reading of the manuscript. R.C. is supported by SNF (310030_212553; 320030E_215576, CRSK\u20103_190550; IZSEZ0_204655; IZSEZ0_218166), Novartis Foundation (22B140), Vontobel Stiftung (41309), UZH\u2010STWF (F\u201041309\u201001\u201001) and the UZH\u2010URPP (Translational Cancer Research). K.Y. is supported by a BioMedTech Entrepreneur Fellowship, BRIDGE\u2010SNF (40B1\u20100_221565) and GRS\u2010Innobooster (GRS\u2010069/23). Funding for open access charge: SNSF\u2010Chronoshub.R.C. is supported by\u00A0SNF\u00A0(310030_212553; 320030E_215576, CRSK-3_190550; IZSEZ0_204655; IZSEZ0_218166),\u00A0Novartis Foundation\u00A0(22B140),\u00A0Vontobel\u00A0Stiftung (41309), UZH-STWF\u00A0(F-41309-01-01) and the UZH-URPP (Translational Cancer Research). K.Y. is supported by a BioMedTech Entrepreneur Fellowship, BRIDGE-SNF (40B1-0_221565) and GRS-Innobooster (GRS-069/23). Funding for open access charge: SNSF-Chronoshub.We thank the Exeter Sequencing facility particularly Paul O'Neil and Karen Moore for help and advice. Christian Hacker and UZH microscopy facility for TEM support and advice. Bogdan Mateescu for discussions. Profs Matthew Scharff and Christian M\u00FCnz for critical reading of the manuscript. R.C. is supported by\u00A0SNF\u00A0(310030_212553; 320030E_215576, CRSK-3_190550; IZSEZ0_204655; IZSEZ0_218166),\u00A0Novartis Foundation\u00A0(22B140),\u00A0Vontobel\u00A0Stiftung (41309), UZH-STWF\u00A0(F-41309-01-01) and the UZH-URPP (Translational Cancer Research). K.Y. is supported by a BioMedTech Entrepreneur Fellowship, BRIDGE-SNF (40B1-0_221565) and GRS-Innobooster (GRS-069/23). Funding for open access charge: SNSF-Chronoshub.: R.C. is supported by SNF (310030_212553; 320030E_215576, CRSK\u20103_190550; IZSEZ0_204655; IZSEZ0_218166), Novartis Foundation (22B140), Vontobel Stiftung (41309), UZH\u2010STWF (F\u201041309\u201001\u201001) and the UZH\u2010URPP (Translational Cancer Research). K.Y. is supported by a BioMedTech Entrepreneur Fellowship, BRIDGE\u2010SNF (40B1\u20100_221565) and GRS\u2010Innobooster (GRS\u2010069/23). Funding for open access charge: SNSF\u2010Chronoshub. Funding
Available on ORBilu :
since 20 March 2026

Statistics


Number of views
35 (1 by Unilu)
Number of downloads
6 (0 by Unilu)

Scopus citations®
 
3
Scopus citations®
without self-citations
2
OpenCitations
 
1
OpenAlex citations
 
3
WoS citations
 
3

Bibliography


Similar publications



Contact ORBilu